The content on this page is intended for members of the public.

Products

Names and compounds of our products

Lundbeck has a broad range of products within brain diseases. With registered products in more than 100 countries, we leverage our global presence to bring innovative therapies to people living with brain diseases around the world.

Report an Adverse Event:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Adverse events should also be reported to Lundbeck Limited, Medical Information on 01908 638972 or at SafetyLuUnitedKingdom@lundbeck.com.

Report an Adverse Drug Reaction

Reporting of potential adverse drug reactions is important in order for us to continuously evaluate the benefits and risks of our products and take proactive action as warranted.

Report Adverse Drug Reaction

Lundbeck Ltd UK distributed or promoted products

All our products are prescription-only medicines (POM). If more information is required, please refer to the local Summary of Product Characteristics (SPC) or Patient Information Leaflet (PIL) using the links below.

Medicines in Great Britain>

Medicines in Northern Ireland>

For Abilify® (aripiprazole) and Abilify Maintena® (aripiprazole), medicines which are marketed jointly with Otsuka who are the Marketing Authorisation (MA) holder, please use the links below. All other medicines can be found at the links above.

Medicines in Great Britain>

Medicines in Northern Ireland>